TOPIC: Featured News, Medical, Patients & Members, Research, Industry, Get Involved
Education has always been a key component of NORD’s mission and this year we expanded our outreach to two vitally important audiences – medical professionals and students preparing for health-related careers.
Today’s healthcare professionals are aware that… Read More
TOPIC: Featured News
TOPIC: Featured News
Next week, a Food and Drug Administration panel of experts will hold the first of two meetings to review two drugs designed to slow the muscle wasting effects associated with Duchenne Muscular Dystrophy (DMD). These much-anticipated events provide hope for children and families living with this devastating and fatal… Read More
TOPIC: Advocacy
The National Organization for Rare Disorders (NORD) today urged the Senate HELP Committee to move quickly to advance the confirmation of Robert Califf, M.D., as the next Commissioner of the Food and Drug Administration (FDA). Dr. Califf’s Senate confirmation hearing is scheduled to take place today. He was nominated by the President in September.
